Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes of Photobiomodulation in DRy Age Related macUlar Degeneration: a proSpective multicEnter raNdomized Controlled (DRUSEN) Study

NCT06046118 is registered in ClinicalTrials.gov with Azienda Ospedaliera Universitaria Mater Domini, Catanzaro as lead sponsor.

NCT NCT06046118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06046118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes of Photobiomodulation in DRy Age Related macUlar Degeneration: a proSpective multicEnter raNdomized Controlled (DRUSEN) Study
Lead sponsor
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro
Phase
Not applicable
Overall status
Recruiting
Start date
April 1, 2023
Completion date
December 31, 2024
Enrollment
180 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration